Prevention  ||| S:0 E:11 ||| NN
of  ||| S:11 E:14 ||| IN
chronic  ||| S:14 E:22 ||| JJ
wound  ||| S:22 E:28 ||| NN
infection  ||| S:28 E:38 ||| VBD
An  ||| S:38 E:41 ||| DT
integral  ||| S:41 E:50 ||| JJ
follow-up  ||| S:50 E:60 ||| NN
of  ||| S:60 E:63 ||| IN
the  ||| S:63 E:67 ||| DT
patient  ||| S:67 E:75 ||| NN
starting  ||| S:75 E:84 ||| VBG
with  ||| S:84 E:89 ||| IN
medical  ||| S:89 E:97 ||| JJ
history ||| S:97 E:104 ||| NN
,  ||| S:104 E:106 ||| ,
present  ||| S:106 E:114 ||| JJ
status  ||| S:114 E:121 ||| NN
and  ||| S:121 E:125 ||| CC
the  ||| S:125 E:129 ||| DT
wound  ||| S:129 E:135 ||| NN
itself  ||| S:135 E:142 ||| PRP
will  ||| S:142 E:147 ||| MD
lead  ||| S:147 E:152 ||| VB
us  ||| S:152 E:155 ||| PRP
to  ||| S:155 E:158 ||| TO
decide  ||| S:158 E:165 ||| VB
which  ||| S:165 E:171 ||| WDT
plan  ||| S:171 E:176 ||| VBP
of  ||| S:176 E:179 ||| IN
prevention ||| S:179 E:189 ||| NN
,  ||| S:189 E:191 ||| ,
care  ||| S:191 E:196 ||| NN
and  ||| S:196 E:200 ||| CC
treatment  ||| S:200 E:210 ||| NN
will  ||| S:210 E:215 ||| MD
be  ||| S:215 E:218 ||| VB
efficient ||| S:218 E:227 ||| JJ
.  ||| S:227 E:229 ||| .
The  ||| S:229 E:233 ||| DT
interaction  ||| S:233 E:245 ||| NN
of  ||| S:245 E:248 ||| IN
host  ||| S:248 E:253 ||| NN
immune  ||| S:253 E:260 ||| JJ
abnormalities  ||| S:260 E:274 ||| NN
and  ||| S:274 E:278 ||| CC
growth  ||| S:278 E:285 ||| NN
of  ||| S:285 E:288 ||| IN
the  ||| S:288 E:292 ||| DT
microbial  ||| S:292 E:302 ||| JJ
population  ||| S:302 E:313 ||| NN
invading  ||| S:313 E:322 ||| VBG
the  ||| S:322 E:326 ||| DT
wound  ||| S:326 E:332 ||| NNS
have  ||| S:332 E:337 ||| VBP
a  ||| S:337 E:339 ||| DT
significant  ||| S:339 E:351 ||| JJ
impact  ||| S:351 E:358 ||| NN
on  ||| S:358 E:361 ||| IN
the  ||| S:361 E:365 ||| DT
clinical  ||| S:365 E:374 ||| JJ
presentation  ||| S:374 E:387 ||| NN
and  ||| S:387 E:391 ||| CC
direction  ||| S:391 E:401 ||| NN
of  ||| S:401 E:404 ||| IN
the  ||| S:404 E:408 ||| DT
development  ||| S:408 E:420 ||| NN
of  ||| S:420 E:423 ||| IN
the  ||| S:423 E:427 ||| DT
wound ||| S:427 E:432 ||| NN
.  ||| S:432 E:434 ||| .
Infection  ||| S:434 E:444 ||| NN
of  ||| S:444 E:447 ||| IN
a  ||| S:447 E:449 ||| DT
chronic  ||| S:449 E:457 ||| JJ
wound  ||| S:457 E:463 ||| NN
is  ||| S:463 E:466 ||| VBZ
a  ||| S:466 E:468 ||| DT
consequence  ||| S:468 E:480 ||| NN
of  ||| S:480 E:483 ||| IN
a  ||| S:483 E:485 ||| DT
large  ||| S:485 E:491 ||| JJ
number  ||| S:491 E:498 ||| NN
and  ||| S:498 E:502 ||| CC
composition  ||| S:502 E:514 ||| NN
of  ||| S:514 E:517 ||| IN
microbe  ||| S:517 E:525 ||| JJ
populations  ||| S:525 E:537 ||| NNS
in  ||| S:537 E:540 ||| IN
the  ||| S:540 E:544 ||| DT
tissue ||| S:544 E:550 ||| NN
,  ||| S:550 E:552 ||| ,
along  ||| S:552 E:558 ||| RB
with  ||| S:558 E:563 ||| IN
the  ||| S:563 E:567 ||| DT
presence  ||| S:567 E:576 ||| NN
of  ||| S:576 E:579 ||| IN
virulence  ||| S:579 E:589 ||| JJ
factors  ||| S:589 E:597 ||| NNS
depending  ||| S:597 E:607 ||| VBG
on  ||| S:607 E:610 ||| IN
the  ||| S:610 E:614 ||| DT
type  ||| S:614 E:619 ||| NN
and  ||| S:619 E:623 ||| CC
representation  ||| S:623 E:638 ||| NN
in  ||| S:638 E:641 ||| IN
the  ||| S:641 E:645 ||| DT
biofilm  ||| S:645 E:653 ||| NN
as  ||| S:653 E:656 ||| IN
a  ||| S:656 E:658 ||| DT
factor  ||| S:658 E:665 ||| NN
of  ||| S:665 E:668 ||| IN
greatest  ||| S:668 E:677 ||| JJS
importance ||| S:677 E:687 ||| NN
,  ||| S:687 E:689 ||| ,
the  ||| S:689 E:693 ||| DT
synergy  ||| S:693 E:701 ||| NN
of  ||| S:701 E:704 ||| IN
various  ||| S:704 E:712 ||| JJ
microbial  ||| S:712 E:722 ||| JJ
communities  ||| S:722 E:734 ||| NNS
of  ||| S:734 E:737 ||| IN
aerobes-anaerobes  ||| S:737 E:755 ||| JJ
in  ||| S:755 E:758 ||| IN
various  ||| S:758 E:766 ||| JJ
combinations ||| S:766 E:778 ||| NNS
,  ||| S:778 E:780 ||| ,
and  ||| S:780 E:784 ||| CC
the  ||| S:784 E:788 ||| DT
host  ||| S:788 E:793 ||| NN
immune  ||| S:793 E:800 ||| JJ
response ||| S:800 E:808 ||| NN
.  ||| S:808 E:810 ||| .
The  ||| S:810 E:814 ||| DT
basic  ||| S:814 E:820 ||| JJ
procedures  ||| S:820 E:831 ||| NNS
in  ||| S:831 E:834 ||| IN
preventing  ||| S:834 E:845 ||| VBG
the  ||| S:845 E:849 ||| DT
development  ||| S:849 E:861 ||| NN
of  ||| S:861 E:864 ||| IN
infection  ||| S:864 E:874 ||| NN
from  ||| S:874 E:879 ||| IN
the  ||| S:879 E:883 ||| DT
colonization  ||| S:883 E:896 ||| JJ
status  ||| S:896 E:903 ||| NN
are  ||| S:903 E:907 ||| VBP
reduction  ||| S:907 E:917 ||| NN
of  ||| S:917 E:920 ||| IN
the  ||| S:920 E:924 ||| DT
total  ||| S:924 E:930 ||| JJ
mass  ||| S:930 E:935 ||| NN
of  ||| S:935 E:938 ||| IN
microbes  ||| S:938 E:947 ||| VBG
along  ||| S:947 E:953 ||| RP
with  ||| S:953 E:958 ||| IN
necrotic  ||| S:958 E:967 ||| JJ
tissue ||| S:967 E:973 ||| NN
,  ||| S:973 E:975 ||| ,
removal  ||| S:975 E:983 ||| NN
or  ||| S:983 E:986 ||| CC
destruction  ||| S:986 E:998 ||| NN
of  ||| S:998 E:1001 ||| IN
virulent  ||| S:1001 E:1010 ||| JJ
factors  ||| S:1010 E:1018 ||| NNS
such  ||| S:1018 E:1023 ||| JJ
as  ||| S:1023 E:1026 ||| IN
the  ||| S:1026 E:1030 ||| DT
biofilm ||| S:1030 E:1037 ||| NN
,  ||| S:1037 E:1039 ||| ,
destruction  ||| S:1039 E:1051 ||| NN
of  ||| S:1051 E:1054 ||| IN
the  ||| S:1054 E:1058 ||| DT
synergy  ||| S:1058 E:1066 ||| NN
of  ||| S:1066 E:1069 ||| IN
various  ||| S:1069 E:1077 ||| JJ
microbial  ||| S:1077 E:1087 ||| JJ
communities ||| S:1087 E:1098 ||| NNS
,  ||| S:1098 E:1100 ||| ,
and  ||| S:1100 E:1104 ||| CC
increasing  ||| S:1104 E:1115 ||| VBG
the  ||| S:1115 E:1119 ||| DT
level  ||| S:1119 E:1125 ||| NN
and  ||| S:1125 E:1129 ||| CC
quality  ||| S:1129 E:1137 ||| NN
of  ||| S:1137 E:1140 ||| IN
the  ||| S:1140 E:1144 ||| DT
host  ||| S:1144 E:1149 ||| NN
immune  ||| S:1149 E:1156 ||| JJ
response ||| S:1156 E:1164 ||| NN
.  ||| S:1164 E:1166 ||| .
Prevention  ||| S:1166 E:1177 ||| NN
of  ||| S:1177 E:1180 ||| IN
the  ||| S:1180 E:1184 ||| DT
chronic  ||| S:1184 E:1192 ||| JJ
wound  ||| S:1192 E:1198 ||| NN
infection  ||| S:1198 E:1208 ||| NN
demands  ||| S:1208 E:1216 ||| NNS
numerous  ||| S:1216 E:1225 ||| JJ
strategies  ||| S:1225 E:1236 ||| NNS
or  ||| S:1236 E:1239 ||| CC
procedures ||| S:1239 E:1249 ||| NNS
,  ||| S:1249 E:1251 ||| ,
which  ||| S:1251 E:1257 ||| WDT
should  ||| S:1257 E:1264 ||| MD
be  ||| S:1264 E:1267 ||| VB
applied  ||| S:1267 E:1275 ||| VBN
simultaneously ||| S:1275 E:1289 ||| RB
,  ||| S:1289 E:1291 ||| ,
but  ||| S:1291 E:1295 ||| CC
must  ||| S:1295 E:1300 ||| MD
rapidly  ||| S:1300 E:1308 ||| RB
and  ||| S:1308 E:1312 ||| CC
frequently  ||| S:1312 E:1323 ||| RB
follow  ||| S:1323 E:1330 ||| VB
each  ||| S:1330 E:1335 ||| DT
other  ||| S:1335 E:1341 ||| JJ
in  ||| S:1341 E:1344 ||| IN
succession ||| S:1344 E:1354 ||| NN
.  ||| S:1354 E:1356 ||| .
Therefore ||| S:1356 E:1365 ||| RB
,  ||| S:1365 E:1367 ||| ,
various  ||| S:1367 E:1375 ||| JJ
methods  ||| S:1375 E:1383 ||| NNS
are  ||| S:1383 E:1387 ||| VBP
being  ||| S:1387 E:1393 ||| VBG
applied  ||| S:1393 E:1401 ||| VBN
depending  ||| S:1401 E:1411 ||| VBG
on  ||| S:1411 E:1414 ||| IN
the  ||| S:1414 E:1418 ||| DT
indications ||| S:1418 E:1429 ||| NNS
,  ||| S:1429 E:1431 ||| ,
such  ||| S:1431 E:1436 ||| JJ
as  ||| S:1436 E:1439 ||| IN
mechanical  ||| S:1439 E:1450 ||| JJ
washing  ||| S:1450 E:1458 ||| NN
and  ||| S:1458 E:1462 ||| CC
cleaning ||| S:1462 E:1470 ||| NN
,  ||| S:1470 E:1472 ||| ,
application  ||| S:1472 E:1484 ||| NN
of  ||| S:1484 E:1487 ||| IN
antiseptics ||| S:1487 E:1498 ||| NN
,  ||| S:1498 E:1500 ||| ,
debridement ||| S:1500 E:1511 ||| NN
,  ||| S:1511 E:1513 ||| ,
vacuum-assisted  ||| S:1513 E:1529 ||| JJ
closing  ||| S:1529 E:1537 ||| NN
of  ||| S:1537 E:1540 ||| IN
the  ||| S:1540 E:1544 ||| DT
wound ||| S:1544 E:1549 ||| NN
,  ||| S:1549 E:1551 ||| ,
oxygenation ||| S:1551 E:1562 ||| NN
,  ||| S:1562 E:1564 ||| ,
moist  ||| S:1564 E:1570 ||| JJ
wound  ||| S:1570 E:1576 ||| NN
healing  ||| S:1576 E:1584 ||| NN
-  ||| S:1584 E:1586 ||| :
active  ||| S:1586 E:1593 ||| JJ
and  ||| S:1593 E:1597 ||| CC
passive  ||| S:1597 E:1605 ||| JJ
compresses ||| S:1605 E:1615 ||| NN
,  ||| S:1615 E:1617 ||| ,
methods  ||| S:1617 E:1625 ||| NNS
of  ||| S:1625 E:1628 ||| IN
removal  ||| S:1628 E:1636 ||| NN
or  ||| S:1636 E:1639 ||| CC
destruction  ||| S:1639 E:1651 ||| NN
of  ||| S:1651 E:1654 ||| IN
the  ||| S:1654 E:1658 ||| DT
biofilm ||| S:1658 E:1665 ||| NN
,  ||| S:1665 E:1667 ||| ,
application  ||| S:1667 E:1679 ||| NN
of  ||| S:1679 E:1682 ||| IN
specific  ||| S:1682 E:1691 ||| JJ
cells ||| S:1691 E:1696 ||| NNS
,  ||| S:1696 E:1698 ||| ,
i.e.  ||| S:1698 E:1703 ||| FW
factors  ||| S:1703 E:1711 ||| NNS
of  ||| S:1711 E:1714 ||| IN
growth ||| S:1714 E:1720 ||| NN
,  ||| S:1720 E:1722 ||| ,
and  ||| S:1722 E:1726 ||| CC
removal  ||| S:1726 E:1734 ||| NN
of  ||| S:1734 E:1737 ||| IN
mechanical  ||| S:1737 E:1748 ||| JJ
stress ||| S:1748 E:1754 ||| NN
.  ||| S:1754 E:1756 ||| .
Antibiotics  ||| S:1756 E:1768 ||| NNS
are  ||| S:1768 E:1772 ||| VBP
not  ||| S:1772 E:1776 ||| RB
used  ||| S:1776 E:1781 ||| VBN
in  ||| S:1781 E:1784 ||| IN
the  ||| S:1784 E:1788 ||| DT
prevention  ||| S:1788 E:1799 ||| NN
of  ||| S:1799 E:1802 ||| IN
chronic  ||| S:1802 E:1810 ||| JJ
wound  ||| S:1810 E:1816 ||| NN
infection ||| S:1816 E:1825 ||| NN
.  ||| S:1825 E:1827 ||| .
They  ||| S:1827 E:1832 ||| PRP
are  ||| S:1832 E:1836 ||| VBP
used  ||| S:1836 E:1841 ||| VBN
only  ||| S:1841 E:1846 ||| RB
in  ||| S:1846 E:1849 ||| IN
a  ||| S:1849 E:1851 ||| DT
targeted  ||| S:1851 E:1860 ||| JJ
fashion  ||| S:1860 E:1868 ||| NN
when  ||| S:1868 E:1873 ||| WRB
infection  ||| S:1873 E:1883 ||| NN
has  ||| S:1883 E:1887 ||| VBZ
been  ||| S:1887 E:1892 ||| VBN
proven  ||| S:1892 E:1899 ||| VBN
and  ||| S:1899 E:1903 ||| CC
the  ||| S:1903 E:1907 ||| DT
agent  ||| S:1907 E:1913 ||| NN
identified ||| S:1913 E:1923 ||| VBN
,  ||| S:1923 E:1925 ||| ,
as  ||| S:1925 E:1928 ||| RB
well  ||| S:1928 E:1933 ||| RB
as  ||| S:1933 E:1936 ||| IN
its  ||| S:1936 E:1940 ||| PRP$
sensitivity  ||| S:1940 E:1952 ||| NN
to  ||| S:1952 E:1955 ||| TO
antibiotics  ||| S:1955 E:1967 ||| VB
obtained  ||| S:1967 E:1976 ||| VBN
from  ||| S:1976 E:1981 ||| IN
target  ||| S:1981 E:1988 ||| NN
samples ||| S:1988 E:1995 ||| NNS
.  ||| S:1995 E:1997 ||| .
An  ||| S:1997 E:2000 ||| DT
ideal  ||| S:2000 E:2006 ||| JJ
prevention  ||| S:2006 E:2017 ||| NN
would  ||| S:2017 E:2023 ||| MD
be  ||| S:2023 E:2026 ||| VB
a  ||| S:2026 E:2028 ||| DT
method  ||| S:2028 E:2035 ||| NN
that  ||| S:2035 E:2040 ||| WDT
would  ||| S:2040 E:2046 ||| MD
prevent  ||| S:2046 E:2054 ||| VB
the  ||| S:2054 E:2058 ||| DT
development  ||| S:2058 E:2070 ||| NN
of  ||| S:2070 E:2073 ||| IN
the  ||| S:2073 E:2077 ||| DT
wound  ||| S:2077 E:2083 ||| NN
and  ||| S:2083 E:2087 ||| CC
be  ||| S:2087 E:2090 ||| VB
applied  ||| S:2090 E:2098 ||| VBN
while  ||| S:2098 E:2104 ||| IN
the  ||| S:2104 E:2108 ||| DT
skin  ||| S:2108 E:2113 ||| NN
is  ||| S:2113 E:2116 ||| VBZ
still  ||| S:2116 E:2122 ||| RB
intact ||| S:2122 E:2128 ||| JJ
.  ||| S:2128 E:2130 ||| .
Irrespective  ||| S:2130 E:2143 ||| RB
of  ||| S:2143 E:2146 ||| IN
all  ||| S:2146 E:2150 ||| DT
knowledge  ||| S:2150 E:2160 ||| NN
accumulated  ||| S:2160 E:2172 ||| VBN
so  ||| S:2172 E:2175 ||| RB
far ||| S:2175 E:2178 ||| RB
,  ||| S:2178 E:2180 ||| ,
the  ||| S:2180 E:2184 ||| DT
good  ||| S:2184 E:2189 ||| JJ
clinical  ||| S:2189 E:2198 ||| JJ
practice  ||| S:2198 E:2207 ||| NN
has  ||| S:2207 E:2211 ||| VBZ
not  ||| S:2211 E:2215 ||| RB
yet  ||| S:2215 E:2219 ||| RB
fully  ||| S:2219 E:2225 ||| RB
defined  ||| S:2225 E:2233 ||| VBN
preventive  ||| S:2233 E:2244 ||| JJ
measures  ||| S:2244 E:2253 ||| NNS
for  ||| S:2253 E:2257 ||| IN
the  ||| S:2257 E:2261 ||| DT
care  ||| S:2261 E:2266 ||| NN
and  ||| S:2266 E:2270 ||| CC
prevention  ||| S:2270 E:2281 ||| NN
of  ||| S:2281 E:2284 ||| IN
chronic  ||| S:2284 E:2292 ||| JJ
wound  ||| S:2292 E:2298 ||| NN
infection ||| S:2298 E:2307 ||| NN
,  ||| S:2307 E:2309 ||| ,
and ||| S:2309 E:2312 ||| CC
,  ||| S:2312 E:2314 ||| ,
likewise ||| S:2314 E:2322 ||| RB
,  ||| S:2322 E:2324 ||| ,
these  ||| S:2324 E:2330 ||| DT
measures  ||| S:2330 E:2339 ||| NNS
are  ||| S:2339 E:2343 ||| VBP
not  ||| S:2343 E:2347 ||| RB
universally  ||| S:2347 E:2359 ||| RB
accepted ||| S:2359 E:2367 ||| VBN
.  ||| S:2367 E:2369 ||| .
The  ||| S:2369 E:2373 ||| DT
aim  ||| S:2373 E:2377 ||| NN
of  ||| S:2377 E:2380 ||| IN
preventive  ||| S:2380 E:2391 ||| JJ
procedures  ||| S:2391 E:2402 ||| NNS
is  ||| S:2402 E:2405 ||| VBZ
at  ||| S:2405 E:2408 ||| IN
the  ||| S:2408 E:2412 ||| DT
same  ||| S:2412 E:2417 ||| JJ
time  ||| S:2417 E:2422 ||| NN
the  ||| S:2422 E:2426 ||| DT
battle  ||| S:2426 E:2433 ||| NN
against  ||| S:2433 E:2441 ||| IN
microbes  ||| S:2441 E:2450 ||| NNS
and  ||| S:2450 E:2454 ||| CC
the  ||| S:2454 E:2458 ||| DT
underlying  ||| S:2458 E:2469 ||| JJ
disease  ||| S:2469 E:2477 ||| NN
that  ||| S:2477 E:2482 ||| WDT
caused  ||| S:2482 E:2489 ||| VBD
the  ||| S:2489 E:2493 ||| DT
development  ||| S:2493 E:2505 ||| NN
of  ||| S:2505 E:2508 ||| IN
chronic  ||| S:2508 E:2516 ||| JJ
wound ||| S:2516 E:2521 ||| NN
,  ||| S:2521 E:2523 ||| ,
with  ||| S:2523 E:2528 ||| IN
the  ||| S:2528 E:2532 ||| DT
aim  ||| S:2532 E:2536 ||| NN
of  ||| S:2536 E:2539 ||| IN
preventing  ||| S:2539 E:2550 ||| VBG
the  ||| S:2550 E:2554 ||| DT
development  ||| S:2554 E:2566 ||| NN
of  ||| S:2566 E:2569 ||| IN
infection ||| S:2569 E:2578 ||| NN
.  ||| S:2578 E:2580 ||| .
